21 U.S.C. § 377 — Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
The Secretary , in carrying into effect the provisions of the Federal Food, Drug, and Cosmetic Act [ 21 U.S.C. 301 et seq.], is authorized on and after July 12, 1943 , to cooperate with associations and scientific societies in the revision of the United States Pharmacopoeia and in the development of methods of analysis and mechanical and physical tests necessary to carry out the work of the Food and Drug Administration . (July 12, 1943, ch. 221, title II, 57 Stat. 500 ; 1953 Reorg. Plan No. 1, § 5, eff. Apr. 11, 1953 , 18 F.R. 2053 , 67 Stat. 631 .) Editorial Notes References in Text The Federal Food, Drug, and Cosmetic Act , referred to in text, is act June 25, 1938, ch. 675, 52 Stat. 1040 , which is classified generally to this chapter. For complete classification of this Act to the Code, see section 301 of this title and Tables. Codification Section was enacted as part of the Labor-Federal Security Appropriation Act, 1944 , and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter. Executive Documents Transfer of Functions For transfer of functions of Federal Security Administrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title . CFR Title Parts 21 5 , 7 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 20 , 25
Related documents
- 21 U.S.C. § 360bbb — Expanded access to unapproved therapies and diagnostics#577309
- 42 U.S.C. § 290c — Advanced Research Projects Agency–Health#595129
- A Clinical Study of HRS-5765 in Healthy Participants#1102193
- 21 U.S.C. § 399h — National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing#577202
- 21 U.S.C. § 1705 — Development, submission, implementation, and assessment of National Drug Control Strategy#576905
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive